发明名称 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases |
摘要 |
The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. |
申请公布号 |
US8853251(B2) |
申请公布日期 |
2014.10.07 |
申请号 |
US201314071090 |
申请日期 |
2013.11.04 |
申请人 |
Allergan, Inc. |
发明人 |
Dibas Mohammed I.;Gil Daniel W.;Chow Ken;Wang Liming;Garst Michael E.;Donello John E. |
分类号 |
A61K31/415;A61K31/4174;A61K31/4164;C07D233/64 |
主分类号 |
A61K31/415 |
代理机构 |
|
代理人 |
Ene Doina G. |
主权项 |
1. A method of treating retinal diseases, selected from dry macular degeneration and geographic atrophy, in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of a compound having Formula I, its individual enantiomers, its individual tautomers or a pharmaceutically acceptable salt thereof,
thereof, wherein R1 is H or C1-3 alkyl; R2 is H or C1-3 alkyl; R3 is H, C1-10 alkyl, heterocycle or aryl; and R is C1-10 alkyl, heterocycle or aryl. |
地址 |
Irvine CA US |